Lv1
30 积分 2022-02-24 加入
Emerging EGFR-Targeted Therapy in Head and Neck Cancer
1小时前
已完结
Association of anti-PD-1 therapy with severe radiation-induced oral mucositis: A retrospective cohort study and validation in the CONTINUUM trial
18小时前
已完结
Becotatug Vedotin: First Approval
7天前
已完结
Becotatug vedotin, MRG003, in previously treated recurrent or metastatic nasopharyngeal carcinoma: A multicenter, single-arm, phase IIa trial
7天前
已完结
Clinical and Morphologic Characteristics of Fibroblast Growth Factor Receptor Inhibitor–Associated Retinopathy
10天前
已完结
Current Progress and Future Directions of Immunotherapy in Head and Neck Squamous Cell Carcinoma
11天前
已完结
Head and Neck Cancer
17天前
已完结
Novel PD-L1 Small-Molecule Inhibitors Advancing Cancer Immunotherapy
18天前
已完结
Phase 2 Trial of Regorafenib in Recurrent/Metastatic Adenoid Cystic Carcinoma
25天前
已完结
Neoadjuvant Immunotherapy and Chemoimmunotherapy Regimens in Head and Neck Cancer
1个月前
已关闭
皖公网安备34019202002308
